What Kura Oncology, Inc.'s executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 2 | 2 |
| Sells | 12 | 40 |
| Total trades | 15 | 58 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 230,000 | 949,020 |
| Disposed | 153,881 | 368,073 |
| Net activity | +76,119 | +580,947 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Powl Brian T. | Chief Commercial Officer | Sep 29 | Disclosed 10b5-1 sale · S | −15,430 | $10.75 | −$166K | 136,819 |
| Leoni Mollie | Chief Medical Officer | Sep 29 | Disclosed 10b5-1 sale · S | −28,802 | $10.75 | −$310K | 141,095 |
| Ford Kathleen | Chief Operating Officer | Sep 29 | Disclosed 10b5-1 sale · S | −3,668 | $10.75 | −$39.4K | 142,986 |
| Bair Teresa Brophy | Chief Legal Officer | Sep 28 | Open-market sale · S | −8,442 | $10.50 | −$88.6K | 187,002 |
| Doyle Thomas James | SVP, Finance & Accounting | Sep 28 | Open-market sale · S | −4,607 | $10.50 | −$48.4K | 142,428 |
| Powl Brian T. | Chief Commercial Officer | Sep 28 | Disclosed 10b5-1 sale · S | −8,000 | $10.56 | −$84.5K | 152,249 |
| Powl Brian T. | Chief Commercial Officer | Sep 28 | Disclosed 10b5-1 sale · S | −9,020 | $10.50 | −$94.7K | 160,249 |
| Leoni Mollie | Chief Medical Officer | Sep 28 | Disclosed 10b5-1 sale · S | −12,448 | $10.50 | −$131K | 169,897 |
| Ford Kathleen | Chief Operating Officer | Sep 28 | Disclosed 10b5-1 sale · S | −6,906 | $10.50 | −$72.5K | 146,654 |
| Burrows Francis | Chief Scientific Officer | Sep 24 | Open-market sale · S | −20,726 | $10.83 | −$225K | 42,327 |
| Burrows Francis | Chief Scientific Officer | Sep 24 | Exercise / conversion · M | +30,000 | $6.15 | +$185K | 63,053 |
| Wilson Troy Edward | President and CEO | Aug 24 | Open-market buy · P | +100,000 | $12.39 | +$1.24M | 479,194 |
| Powl Brian T. | Chief Commercial Officer | Aug 21 | Open-market sale · S | −4,345 | $11.89 | −$51.7K | 169,269 |
| Bair Teresa Brophy | Chief Legal Officer | Aug 19 | Disclosed 10b5-1 sale · S | −31,487 | $12.63 | −$398K | 195,444 |
| Wilson Troy Edward | President and CEO | Aug 17 | Open-market buy · P | +100,000 | $11.12 | +$1.11M | 379,194 |
| Leoni Mollie | Chief Medical Officer | Jun 18 | Disclosed 10b5-1 sale · S | −84,929 | $9.82 | −$834K | 182,345 |
| Powl Brian T. | Chief Commercial Officer | May 21 | Open-market sale · S | −10,000 | $11.00 | −$110K | 173,614 |
| Powl Brian T. | Chief Commercial Officer | May 19 | Open-market sale · S | −339 | $9.21 | −$3.12K | 183,614 |
| Ford Kathleen | Chief Operating Officer | May 19 | Open-market sale · S | −2,257 | $9.08 | −$20.5K | 153,560 |
| Bair Teresa Brophy | Chief Legal Officer | May 18 | Open-market sale · S | −2,256 | $9.38 | −$21.2K | 226,931 |
Loading...
